0001209191-23-035563.txt : 20230608
0001209191-23-035563.hdr.sgml : 20230608
20230608181459
ACCESSION NUMBER: 0001209191-23-035563
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Muralidhar Bali
CENTRAL INDEX KEY: 0001784138
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 231003289
MAIL ADDRESS:
STREET 1: C/O EXICURE, INC.
STREET 2: 8045 LAMON AVENUE, SUITE 410
CITY: SKOKIE
STATE: IL
ZIP: 60077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-06
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001784138
Muralidhar Bali
C/O RENEO PHARMACEUTICALS, INC.
18575 JAMBOREE ROAD, SUITE 275-S
IRVINE
CA
92612
1
0
0
0
0
Stock Option (right to buy)
9.01
2023-06-06
4
A
0
17500
0.00
A
2033-06-05
Common Stock
17500
17500
D
The shares subject to the option vest on the earlier of June 6, 2024 or the day prior to the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.
/s/ Jennifer P. Lam, Attorney-in-Fact
2023-06-08
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Gregory J. Flesher, Michael P. Cruse and Jennifer P. Lam of Reneo
Pharmaceuticals, Inc. (the Company), signing individually, the undersigned's
true and lawful attorney-in fact and agent to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of the Company, Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the Exchange Act) and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-facts discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-facts substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that each of the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming, nor is the Company assuming, any of the
undersigneds responsibilities to comply with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigneds holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact
shall no longer be employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 22nd day of July, 2022.
/s/ Bali Muralidhar
Bali Muralidhar